Skip to content

The mission to improve patient outcomes

Prostate cancer will affect 1 in 7 men. The standards for screening and biopsy blindly sample the prostate without knowing where the cancer is, if any. We’re here to set a new standard of care with MRI-targeted fusion biopsies.

The Problem

The “one size fits all” approach is the current standard of care for prostate cancer. While it may get the job done, systematic biopsies can lead to delayed diagnoses, more advanced cancer and fewer treatment options.

systematic biopsy workflow

The Solution

Our products make MRI-targeted biopsies more accurate, efficient and accessible, so physicians can deliver diagnoses faster. When caught early, prostate cancer is not only more treatable, but also gives patients more options for treatment. These focal therapies minimize damage to healthy tissue, giving patients the best chance at maintaining urinary and sexual function.

tree diagram of options

Improves Diagnostic Pathway

MRI could be used as a triage test to avoid biopsy if the results are negative, whereas positive results could be used for targeting regions of interest during biopsy.

treatment options slider

More Treatment Options

The targeted approach opens the door to less invasive procedures such as cryotherapy, high intensity focused ultrasound (HIFU) and irreversible electroporation (IRE) ablation.

MRI Fusion Pathway

mri targeted biopsy workflow

“The Fusion Bx makes targeted procedures faster and easier to perform. It has opened the door to IRE treatment, allowing me to confidently place needles and electrodes with accuracy and speed.” 

– Dr. Nam, ClearPoint Surgical, Canada

Resources

Learn more about diagnosis, treatment or fusion technology

patient guide to prostate cancer

A Patient’s Guide to Prostate Cancer

Because cancer is a daunting word, let alone journey, we’ve created this guide to help you understand what it may mean for you or your loved ones.

Patient Guide

Most Popular Blog Posts